Valuation: CaliPharms, Inc.

Market Cap 401K 352K 324K 300K 568K 38.27M 577K 3.87M 1.52M 18.85M 1.51M 1.47M 64.88M P/E 2012 *
-
P/E 2013 -0.51x
Enterprise Value 1.07M 936K 863K 797K 1.51M 102M 1.54M 10.31M 4.04M 50.17M 4.01M 3.92M 173M EV / Sales 2012 *
-
EV / Sales 2013 -
Free-Float
100%
Yield 2012 *
-
Yield 2013 -
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0.01
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 13.88K
+0.95%-0.08%-12.82%-8.16% 12.7B
+2.42%+1.37%-33.43%-54.80% 4.67B
-0.02%-0.64%-6.89%-5.76% 4.4B
-7.84%-7.31%+12.48%-9.74% 3.92B
+2.11%-0.70%+4.02%-37.69% 3.73B
-0.58%+6.63%-8.69%-13.03% 3.27B
+0.28%+0.57%-11.39%+2.92% 3.09B
-0.77%+1.24%-7.85%-23.20% 2.42B
-0.32%+4.78%-5.40%+44.70% 1.81B
Average -0.38%-1.02%-7.77%-11.64% 4B
Weighted average by Cap. -0.08%-1.30%-9.44%-14.32%

Financials

2012 2013
Net sales - -
Net income -917K -803K -741K -684K -1.3M -87.44M -1.32M -8.85M -3.47M -43.07M -3.44M -3.37M -148M -216K -190K -175K -162K -306K -20.64M -311K -2.09M -819K -10.17M -813K -795K -35M
Net Debt 617K 540K 498K 460K 873K 58.81M 887K 5.95M 2.33M 28.97M 2.32M 2.26M 99.7M 667K 584K 539K 498K 943K 63.58M 959K 6.43M 2.52M 31.32M 2.5M 2.45M 108M
Logo CaliPharms, Inc.
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. KGET Stock